Case Study: a Fortune 500 multinational packaged foods company improves GI tolerance insights with ObvioHealth

Evaluating efficacy and consumer tolerance of inulin fiber bars

A Fortune 500 multinational packaged foods company sought to launch a new line of fiber snack bars and needed to evaluate the gastrointestinal tolerance and efficacy of four different product formulations. The challenge was to develop and execute a 100% virtual randomized controlled trial with 400 participants across the United States to collect this critical data. To accomplish this, they partnered with ObvioHealth.

ObvioHealth implemented a virtual study solution using their technology to handle recruitment, eConsent, and data capture via ePRO. The study successfully recruited 400 participants in just 24 days and achieved an 85% questionnaire compliance rate with a 92% retention rate. The ObvioHealth platform provided live data dashboards, delivering new insights on GI response and product likeability that directly informed the client's product development and marketing claims.